Back to mobile site

Incyte (INCY) Weakness Seen Related to OPZELURA Sample 'Texture Issues' - Mizuho

November 2, 2021 11:02 AM EDT Send to a Friend
Mizuho Securities analyst Mara Goldstein weighed in on Incyte (NASDAQ: INCY) following Q3 results and its earnings call. The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login